Advertisement
Screener

PRECIGEN, INC. (PGEN) Increase (Decrease) in Prepaid Expense and Other Assets

PRECIGEN, INC. Increase (Decrease) in Prepaid Expense and Other Assets

PRECIGEN, INC. (PGEN) reported Increase (Decrease) in Prepaid Expense and Other Assets of $453.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-04

  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$109.00K.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $562.00K.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$869.00K.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.87M, a 6.12% decline year-over-year.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $93.00K.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$981.00K.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$748.00K.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$2.63M, a 290.17% decline from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30-$109.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$453.00K
10-Q · filed 2026-08-04
-$416.00K
derived: sum of 3 quarters · filed 2026-08-04
$1.46M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$562.00K
10-Q · filed 2026-05-13
-$307.00K
derived: sum of 2 quarters · filed 2026-05-13
$1.56M
derived: sum of 3 quarters · filed 2026-05-13
$701.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$869.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$1.00M
derived: sum of 2 quarters · filed 2026-03-25
$139.00K
derived: sum of 3 quarters · filed 2026-08-04
$93.00K
10-K · filed 2026-03-25
2025-09-30$1.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$1.01M
derived: sum of 2 quarters · filed 2026-08-04
$962.00K
10-Q · filed 2025-11-13
-$855.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$864.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$910.00K
10-Q · filed 2026-08-04
-$2.73M
derived: sum of 3 quarters · filed 2026-08-04
-$733.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31-$46.00K
10-Q · filed 2026-05-13
-$1.86M
derived: sum of 2 quarters · filed 2026-05-13
$131.00K
derived: sum of 3 quarters · filed 2026-05-13
-$328.00K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$1.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$177.00K
derived: sum of 2 quarters · filed 2026-03-25
-$282.00K
derived: sum of 3 quarters · filed 2026-03-25
-$981.00K
10-K · filed 2026-03-25
2024-09-30$1.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$1.53M
derived: sum of 2 quarters · filed 2025-11-13
$836.00K
10-Q · filed 2025-11-13
$26.00K
derived: sum of 4 quarters · filed 2026-03-25
2024-06-30-$459.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$1.16M
10-Q · filed 2025-08-12
-$1.97M
derived: sum of 3 quarters · filed 2026-03-25
$368.00K
derived: sum of 4 quarters · filed 2026-03-25
2024-03-31-$699.00K
10-Q · filed 2025-05-14
-$1.51M
derived: sum of 2 quarters · filed 2026-03-25
$827.00K
derived: sum of 3 quarters · filed 2026-03-25
-$704.00K
derived: sum of 4 quarters · filed 2026-03-25
2023-12-31-$810.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$1.53M
derived: sum of 2 quarters · filed 2026-03-25
-$5.00K
derived: sum of 3 quarters · filed 2026-03-25
-$748.00K
10-K · filed 2026-03-25
2023-09-30$2.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$805.00K
derived: sum of 2 quarters · filed 2024-11-14
$62.00K
10-Q · filed 2024-11-14
-$1.47M
derived: sum of 4 quarters · filed 2025-03-19
2023-06-30-$1.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$2.27M
10-Q · filed 2024-08-14
-$3.80M
derived: sum of 3 quarters · filed 2025-03-19
-$620.00K
derived: sum of 4 quarters · filed 2025-03-19
2023-03-31-$743.00K
10-Q · filed 2024-05-14
-$2.27M
derived: sum of 2 quarters · filed 2025-03-19
$911.00K
derived: sum of 3 quarters · filed 2025-03-19
-$1.27M
derived: sum of 4 quarters · filed 2025-03-19
2022-12-31-$1.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19
$1.65M
derived: sum of 2 quarters · filed 2025-03-19
-$528.00K
derived: sum of 3 quarters · filed 2025-03-19
-$2.63M
10-K · filed 2025-03-19
-$289.00K
10-K · filed 2023-03-06
2022-09-30$3.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$999.00K
derived: sum of 2 quarters · filed 2023-11-09
-$1.10M
10-Q · filed 2023-11-09
$1.30M
10-Q · filed 2022-11-09
-$108.00K
derived: sum of 4 quarters · filed 2024-03-19
2022-06-30-$2.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$4.28M
10-Q · filed 2023-08-09
-$3.52M
10-Q · filed 2022-08-08
-$3.29M
derived: sum of 3 quarters · filed 2024-03-19
$893.00K
derived: sum of 4 quarters · filed 2024-03-19
2022-03-31-$2.10M
10-Q · filed 2023-05-10
-$1.57M
10-Q · filed 2022-05-09
-$1.11M
derived: sum of 2 quarters · filed 2024-03-19
$3.08M
derived: sum of 3 quarters · filed 2024-03-19
$125.00K
derived: sum of 4 quarters · filed 2024-03-19
2021-12-31$995.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
$5.18M
derived: sum of 2 quarters · filed 2024-03-19
$2.23M
derived: sum of 3 quarters · filed 2024-03-19
$1.38M
10-K · filed 2024-03-19
-$520.00K
10-K · filed 2022-03-01
2021-09-30$4.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$1.23M
derived: sum of 2 quarters · filed 2022-11-09
$388.00K
10-Q · filed 2022-11-09
-$577.00K
derived: sum of 4 quarters · filed 2023-03-06
2021-06-30-$2.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$3.79M
10-Q · filed 2022-08-08
-$4.76M
derived: sum of 3 quarters · filed 2023-03-06
$279.00K
derived: sum of 4 quarters · filed 2023-03-06
2021-03-31-$844.00K
10-Q · filed 2022-05-09
-$1.81M
derived: sum of 2 quarters · filed 2023-03-06
$3.23M
derived: sum of 3 quarters · filed 2023-03-06
$895.00K
derived: sum of 4 quarters · filed 2023-03-06
2020-12-31-$965.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
$4.07M
derived: sum of 2 quarters · filed 2023-03-06
$1.74M
derived: sum of 3 quarters · filed 2023-03-06
$812.00K
10-K · filed 2023-03-06
2020-09-30$5.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
$2.70M
derived: sum of 2 quarters · filed 2021-11-08
$1.78M
10-Q · filed 2021-11-08
-$281.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$2.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$3.26M
10-Q · filed 2021-08-09
-$5.32M
derived: sum of 3 quarters · filed 2022-03-01
-$954.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$927.00K
10-Q · filed 2021-05-10
-$2.98M
derived: sum of 2 quarters · filed 2022-03-01
$1.38M
derived: sum of 3 quarters · filed 2022-03-01
$1.01M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$2.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$2.31M
derived: sum of 2 quarters · filed 2022-03-01
$1.94M
derived: sum of 3 quarters · filed 2022-03-01
$2.26M
10-K · filed 2022-03-01
2019-09-30$4.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$4.00M
derived: sum of 2 quarters · filed 2020-11-09
$4.32M
10-Q · filed 2020-11-09
$2.80M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30-$367.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$45.00K
10-Q · filed 2020-08-10
-$1.56M
derived: sum of 3 quarters · filed 2021-03-01
$233.00K
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$322.00K
10-Q · filed 2020-05-11
-$1.20M
derived: sum of 2 quarters · filed 2021-03-01
$600.00K
derived: sum of 3 quarters · filed 2021-03-01
$378.00K
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$1.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$278.00K
derived: sum of 2 quarters · filed 2021-03-01
$56.00K
derived: sum of 3 quarters · filed 2021-03-01
-$1.01M
10-K · filed 2021-03-01
2018-09-30$1.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$1.57M
derived: sum of 2 quarters · filed 2019-11-12
$511.00K
10-Q · filed 2019-11-12
-$497.00K
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30-$222.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$1.28M
10-Q · filed 2019-08-09
-$2.29M
derived: sum of 3 quarters · filed 2020-03-02
-$1.30M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31-$1.06M
10-Q · filed 2019-05-09
-$2.07M
derived: sum of 2 quarters · filed 2020-03-02
-$1.08M
derived: sum of 3 quarters · filed 2020-03-02
-$1.34M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31-$1.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
-$21.00K
derived: sum of 2 quarters · filed 2020-03-02
-$282.00K
derived: sum of 3 quarters · filed 2020-03-02
-$492.00K
10-K · filed 2020-03-02
2017-09-30$987.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$726.00K
derived: sum of 2 quarters · filed 2018-11-08
$516.00K
10-Q · filed 2018-11-08
$463.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30-$261.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13
-$471.00K
10-Q · filed 2018-08-13
-$524.00K
derived: sum of 3 quarters · filed 2019-03-01
$1.76M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$210.00K
10-Q/A · filed 2018-08-13
-$263.00K
derived: sum of 2 quarters · filed 2019-03-01
$2.02M
derived: sum of 3 quarters · filed 2019-03-01
$865.00K
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$53.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$2.23M
derived: sum of 2 quarters · filed 2019-03-01
$1.07M
derived: sum of 3 quarters · filed 2019-03-01
$932.00K
10-K · filed 2019-03-01
2016-09-30$2.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$1.13M
derived: sum of 2 quarters · filed 2017-11-09
$985.00K
10-Q · filed 2017-11-09
-$291.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30-$1.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
-$1.30M
10-Q · filed 2017-08-09
-$2.58M
derived: sum of 3 quarters · filed 2018-03-01
-$239.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31-$143.00K
10-Q · filed 2017-05-10
-$1.42M
derived: sum of 2 quarters · filed 2018-03-01
$917.00K
derived: sum of 3 quarters · filed 2018-03-01
$2.29M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31-$1.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$1.06M
derived: sum of 2 quarters · filed 2018-03-01
$2.44M
derived: sum of 3 quarters · filed 2018-03-01
$2.73M
10-K · filed 2018-03-01
2015-09-30$2.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$3.71M
derived: sum of 2 quarters · filed 2016-11-09
$4.00M
10-Q · filed 2016-11-09
$3.79M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$1.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$1.67M
10-Q · filed 2016-08-09
$1.46M
derived: sum of 3 quarters · filed 2017-03-01
$1.90M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$292.00K
10-Q · filed 2016-05-10
$78.00K
derived: sum of 2 quarters · filed 2017-03-01
$522.00K
derived: sum of 3 quarters · filed 2017-03-01
$759.00K
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$214.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$230.00K
derived: sum of 2 quarters · filed 2017-03-01
$467.00K
derived: sum of 3 quarters · filed 2017-03-01
$465.00K
10-K · filed 2017-03-01
2014-09-30$444.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$681.00K
derived: sum of 2 quarters · filed 2015-11-09
$679.00K
10-Q · filed 2015-11-09
$398.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$237.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$235.00K
10-Q · filed 2015-08-10
-$46.00K
derived: sum of 3 quarters · filed 2016-02-29
$1.33M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$2.00K
10-Q · filed 2015-05-11
-$283.00K
derived: sum of 2 quarters · filed 2016-02-29
$1.09M
derived: sum of 3 quarters · filed 2016-02-29
$454.00K
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$281.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$1.09M
derived: sum of 2 quarters · filed 2016-02-29
$456.00K
derived: sum of 3 quarters · filed 2016-02-29
$347.00K
10-K · filed 2016-02-29
2013-09-30$1.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
$737.00K
derived: sum of 2 quarters · filed 2014-11-13
$628.00K
10-Q · filed 2014-11-13
$506.00K
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30-$638.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
-$747.00K
10-Q · filed 2014-08-14
-$869.00K
derived: sum of 3 quarters · filed 2015-03-02
-$939.00K
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31-$109.00K
10-Q · filed 2014-05-09
-$231.00K
derived: sum of 2 quarters · filed 2015-03-02
-$301.00K
derived: sum of 3 quarters · filed 2015-03-02
2012-12-31-$122.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$192.00K
derived: sum of 2 quarters · filed 2015-03-02
$413.00K
10-K · filed 2015-03-02
2012-09-30-$70.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07
$535.00K
10-Q · filed 2013-11-07
2012-06-30$605.00K
10-Q/A · filed 2013-10-21
2011-12-31$772.00K
10-K · filed 2014-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Immunome Inc. (IMNM)United States$2.538B-9.45
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67